Chemoinformaics analysis of 3-METHYL-2-OCTENE
| Molecular Weight | 126.243 | nRot | 4 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 1 |
| Exact Molecular Weight | 126.141 | nRing | 0 |
| Solubility: LogS | -4.351 | nHRing | 0 |
| Solubility: LogP | 4.82 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.0323 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.399 |
| Synth | 2.242 |
| Natural Product Likeliness | 1.805 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.006 |
| HIA | 0.003 |
| CACO-2 | -4.238 |
| MDCK | 0.0000184 |
| BBB | 0.824 |
| PPB | 0.969528 |
| VDSS | 4.224 |
| FU | 0.0399703 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.547 |
| CYP2c19-inh | 0.554 |
| CYP2c19-sub | 0.758 |
| CYP2c9-inh | 0.367 |
| CYP2c9-sub | 0.878 |
| CYP2d6-inh | 0.091 |
| CYP2d6-sub | 0.134 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.172 |
| CL | 9.814 |
| T12 | 0.369 |
| hERG | 0.012 |
| Ames | 0.005 |
| ROA | 0.021 |
| SkinSen | 0.72 |
| Carcinogencity | 0.073 |
| EI | 0.988 |
| Respiratory | 0.136 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.944793 |